BTG2 and lung carcinoma: First, over‐expression of BTG2 is known to inhibit proliferation of cells and invasion in some tumours, including lung cancer cells (Wei et al., 2012), and acts as an anti‐proliferation gene in cooperation with PRMT1 (Dolezal et al., 2017).